Biomarkers & Precision Medicine USA Congress 2016

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers

5 Interactive Streams:

  • Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
  • Personalised Medicine, Companion Diagnostics & Patient Testing
  • Innovations In Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
  • Biomarker in Clinical Development & Clinical Trials
  • Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Co- located with the 3rd Annual Drug Discovery USA Congress, 3-4 October 2016, San Diego , USA

Oxford Global Conferences are proud to present the Biomarkers & Precision Medicine USA Congress, taking place on the 3-4th October 2016 in San Diego, USA.

Attended by over 200 participants from the pharmaceutical industry, the congress offers a balance of scientific presentations and unprecedented networking opportunities. In line with the current industry trends, day one of the congress focusses on the identification of safety biomarkers, the translation of biomarkers from the discovery to the early development stages as well as personalised healthcare. Expert case studies will also cover insights into novel biomarker discoveries and development in different therapeutic areas such as immune-oncology, CNS diseases, neuroscience & infectious diseases.

The companion diagnostics & personalised medicine stream features the latest updates in companion diagnostics developments, regulatory updates and the future of targeted therapy, precision medicine & patient self-monitoring in healthcare.

On day two of the congress, do not miss out on the innovation stream, featuring insightful case study presentations on novel biomarker technologies such as informatics and data management, imaging technologies and cytometry. The emphasis is also on using the most appropriate assays, and to develop these into validated analytical methods suitable for clinical practice.

Building on the success of previous Biomarker events, the Biomarkers & Precision Medicine USA Congress has a featured focus in the role of Biomarkers in Clinical Development. This highlights the role of biomarkers in clinical development, clinical trials and clinical diagnostics. Industry leaders will discuss the ever increasing role of NGS & genomic markers in clinical diagnostics & decision making. Hear the latest case studies on the use of microRNA’s, CTCs and free circulating RNA & DNA as biomarkers in clinical diagnostics.

Over the course of 2 days, our renowned speaker panel will discuss the following topics:

  • Overcoming challenges of clinical validation & translation
  • Surrogate endpoints: utilising biomarkers in clinical trials
  • Implementing biomarker data into clinical development strategies
  • Transforming clinical development through biomarker driven clinical trials design
  • Predictive biomarker discovery in proof – of concept clinical studies
  • NGS for clinical testing & diagnostics
  • Case Studies: mircoRNA’s, CTCs, circulating free DNA & exosomes
  • Biomarkers for non-invasive diagnosis
  • The importance of liquid biopsy’s
  • Clinical effectiveness of diagnostic & screening of new markers

The Biomarkers & Precision Medicine USA Congress forms part of Oxford Global’s highly successful life science series. Upcoming events in the series include:

Biomarkers & Precision Medicine USA and Drug Discovery USA Sponsors 2016:





Media Partners

200AllSeq_Light-Adjusted-300DPIDiagnosticsMDPISmall copyDiagnostics_World_Small copyPMCSmall copy